quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:18:59·518d
INSIDERFiling
Haynes International Inc. logo

VP, SALES AND DISTRIBUTION Losch Marlin C Iii returned 32,672 shares to the company, closing all direct ownership in the company (SEC Form 4)

HAYN· Haynes International Inc.
Industrials
Original source

Companies

  • HAYN
    Haynes International Inc.
    Industrials

Recent analyst ratings

  • Mar 14UpdateNorthcoast-
  • Feb 6UpdateNoble Capital Markets-
  • May 25UpdateNorthcoast$60.00
  • Feb 16UpdateNoble Capital Markets$65.00
  • Nov 15UpdateKeyBanc Capital Markets-
  • Jan 31UpdateKeybanc$41.00

Related

  • SEC507d
    SEC Form 15-12G filed by Haynes International Inc.
  • INSIDER518d
    Director Getz Robert was granted 2,461 shares and returned 41,469 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    PRESIDENT AND CEO Shor Michael L returned 97,706 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    CFO, VP - FINANCE Maudlin Daniel W returned 31,537 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    GENERAL COUNSEL Kohlheim Angela returned 2,775 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    VP, HUMAN RESOURCES Perry Susan returned 1,900 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    VP - RESEARCH AND TECHNOLOGY Pike Lee M returned 2,157 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER518d
    VP - TUBE AND WIRE Pinkham Scott R returned 28,350 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022